封面
市场调查报告书
商品编码
1840715

磁振造影血管血管造影术设备市场(按产品、场强、技术、应用和最终用户)—全球预测 2025-2032

Magnetic Resonance Angiography Market by Product, Field Strength, Technology, Application, End User - Global Forecast 2025-2032

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年,磁振造影血管造影术设备市场将成长至 76.7 亿美元,复合年增长率为 11.38%。

主要市场统计数据
基准年2024年 32.3亿美元
预计2025年 36亿美元
预测年份:2032年 76.7亿美元
复合年增长率(%) 11.38%

简要概述最新的磁振造影血管摄影创新如何与临床需求、业务重点和组织决策交叉

磁振造影血管血管造影术(MRA) 为临床医师提供各种临床环境下的非侵入性血管可视化,在影像创新与血管治疗途径之间发挥关键作用。近期的技术进步降低了操作复杂性,扩大了临床适应症,并提高了患者舒适度,从而使 MRA 从一种小众方法提升为众多血管工作流程中的重要诊断工具。在序列创新、硬体进步和基于软体的影像重建技术的推动下,这些发展再形成了临床医生的期望和采购优先事项。

因此,诊断影像、临床研究和设备製造领域的相关人员必须重新评估MRA如何与其更广泛的诊断策略整合。放射科团队越来越重视吞吐量和诊断信心,而医院管理人员则要求设备能够支援多学科使用且生命週期成本可预测。同时,门诊中心和诊断影像提供者正在评估MRA如何在不造成不可持续的营运负担的情况下增强其服务组合。本介绍将MRA置于当代临床和商业性环境中,强调技术能力、临床应用和组织决策之间的相互作用。

深入了解重新定义磁振造影血管造影术实践和采购的硬体、序列和计算趋势

在硬体、脉衝序列设计和计算影像处理技术的推动下,磁振造影血管摄影 (MRA) 领域正在发生重大变革。高场系统不断突破信噪比极限,实现更高的空间分辨率,而低场系统也因其成本优势和更高的可及性而重新引发人们的兴趣。同时,飞行时间和静止间隔单次激发等非造影技术日益成熟,减少了对钆类药物的依赖,并重塑了肾功能不全或需要重复成像的患者的临床通讯协定。

同时,相位造影序列和先进的造影技术在血流动力学评估方面也得到了改进,有助于更细緻地评估血管血流和病变特征。人工智慧和机器学习在重建、降噪和自动血管分割方面发挥越来越重要的作用,从而缩短了扫描时间并提高了诊断能力。因此,服务模式和耗材工作流程正在不断调整,以支援结合高阶系统、最佳化序列库和增值软体的混合产品。总的来说,这些转变正在重新定义采购标准和临床路径,互通性、可升级性和软体许可正变得与基本硬体规格一样具有影响力。

评估 2025 年美国新关税如何重塑整个磁振造影血管血管造影术设备生态系统的筹资策略、供应链和资本规划

2025年美国新关税的实施将为MRA相关人员创造一个复杂的环境,影响采购週期、采购决策和供应商关係。与关税相关的成本压力可能会提高进口零件和完整影像系统的到岸价格,从而影响医院、诊断中心和门诊机构的资本配置和更换计画。面对不断上升的购买成本,许多买家将推迟升级或优先考虑可分阶段实施的模组化投资,同时更仔细地审查总体拥有成本,包括维护和耗材供应协议。

此外,关税政策将鼓励策略性供应商多元化和近岸外包,促使製造商重组供应链,以降低关税波动带来的风险。随着本地生产相对更具吸引力,关税可能会改变服务供应商和耗材供应商的竞争动态。在这种情况下,采购团队和临床负责人必须将供应链的弹性纳入其采购标准,在短期成本节约的潜力与单一采购的风险之间取得平衡。因此,法规遵循和海关优化变得更加重要,相关人员必须鼓励供应商考虑库存规划和合约的灵活性,以便更好地应对意外关税的影响。总的来说,这些调整将影响整个影像生态系统的资本规划、供应商谈判和营运连续性。

深入的细分综合揭示了产品类型、场强等级、影像技术、临床应用和最终用户概况如何影响 MRA 需求和投资

详细了解市场细分,可以揭示MRA的临床需求和投资集中在何处。依产品分析市场,可以清楚发现配件和耗材、持续服务合约以及资本系统之间的价值流,而係统本身则分为高场强和低场强平台,具有不同的临床能力和生命週期经济性。这种二分法在仅按场强进行细分时也体现出来,因为高场强和低场强平台针对不同的临床用例和设施预算。基于技术的细分显示,造影剂与相位对比、静态间隔单次激发和飞行时间技术共存,每种技术都贡献了各自的诊断强度和特定序列的工作流程要求。

应用细分进一步明确了临床发展轨迹,心血管应用涵盖主动脉和心臟成像需求,神经血管应用区分颅外和颅内成像,週边血管应用区分下肢和上肢成像。这些临床细分与最终用户细分(学术机构、门诊手术中心、诊断影像中心和医院)相互影响,而这些细分市场的采购週期、临床吞吐量预期和人员配置模式存在显着差异。因此,产品、现场能力、技术、应用和最终用户细分形成了相互重迭的需求区域。追踪这些交叉点,使相关人员能够确定投资优先顺序、协调服务内容,并设计与每个细分市场营运实际情况相符的临床检验研究。

全面的区域分析,重点介绍美洲、欧洲、中东和非洲以及亚太地区的不同 MRA 采用模式、采购动态和临床重点

在全球MRA领域,区域动态对技术采用、报销框架和临床实践模式有重大影响。在美洲,临床网路和大型医疗保健系统通常会推动高效能係统和先进定序文库的早期采用。欧洲、中东和非洲 (EMEA) 地区既有成熟的市场,拥有成熟的报销途径,也有新兴的医疗保健系统,优先考虑经济高效、扩充性的解决方案。监管协调工作和跨境临床合作进一步塑造了这些地区的需求。在亚太地区,受诊断基础设施扩张和对非侵入性血管诊断投资增加的推动,都市区的MRA应用正在快速增长,但高所得大都会圈和资源受限地区的市场成熟度差异显着,在这些地区,低机构体系和精简的服务模式可能更为实用。

这些地区在临床指引、训练流程和服务交付模式上的差异,将影响MRA相对于其他影像方式的定位。因此,供应商和服务供应商应根据地区特性制定合作策略,并充分考虑采购週期、当地临床专家和当地法规。此外,与区域研究机构和临床教育计画合作,可以促进临床需求和能力匹配地区的应用,而灵活的商业模式则有助于填补资金有限地区的空白。

策略竞争分析重点在于整合硬体、软体和服务提案如何决定供应商在磁振造影血管血管造影术市场的成功

MRA 生态系统的竞争力日益由硬体、序列库、后处理软体和服务协议的整合提案而非单一设备销售来决定。能够透过强大的软体套件(用于血管分割、流量量化和 AI 辅助重建)补充其係统的目标商标产品製造商,正在重视互通性和清晰蓝图的大型医疗保健系统中占据更有利的地位。同时,专注于耗材、线圈和手术配件的专业供应商则凭藉其临床适用性、易于整合性和可预测的供应链竞争。提供快速维护、远距离诊断和灵活培训计划的服务供应商,为寻求保证运作和员工能力的最终用户提供了切实的价值。

影像IT提供者与临床网路之间的策略伙伴关係也正在成为一种差异化因素,它能够支援纵向资料分析和品质改进计划,从而扩展MRA的临床效用。在这种环境下,那些投资于临床检验、提供透明昇级路径并展现出强大合规性的公司,更有可能赢得复杂且高相关人员的采购决策。对于规模较小的公司而言,专注于利基临床应用、极具吸引力的经济价值提案或新颖的造影和非造影技术,有助于建立广泛的市场地位。最终,成功的关键在于,将产品和服务创新与不同临床环境的营运现实结合,同时透过自适应筹资策略管理供应链和关税相关风险。

为产业领导者提供可操作的策略框架,以优化技术投资、供应链、临床检验和 MRA 解决方案的商业化

产业领导者应采取多管齐下的策略,加速MRA在医疗领域的应用,同时挖掘临床价值并降低外部风险。首先,优先投资定序和软体开发,以显着缩短扫描时间、提升诊断信心并增强临床投资报酬率。同时,应多元化供应链,探索区域製造或组装伙伴关係,以减轻关税影响并缩短前置作业时间。这些营运措施应辅以灵活的商业模式,将资本收购与基本服务和软体收益分开,为买家提供符合其预算和临床时间表的选择。

其次,我们将透过有针对性的检验研究累积临床证据,证明其在主动脉造影、心血管评估、颅内病变特征描述和周边肢体评估等关键用例中的比较表现。第三,我们将投资培训和变革管理项目,帮助放射科团队和技术人员从新的序列和基于人工智慧的工具中获得最大的诊断价值。第四,我们将制定区域上市计划,以反映报销现状、监管差异以及高场和低场系统不同的采用曲线。最后,我们将积极与付款人、卫生系统和临床协会合作,阐明基于磁振造影血管摄影 (MRA) 的途径的临床和经济价值,从而为永续的采用和推广创造有利环境。

对混合方法研究途径,该方法结合了二次审查、一次访谈和严格检验,以确保可靠的 MRA 见解

本研究综合了透过强调三角测量和相关人员检验的混合方法收集的见解。二次分析包括对同行评审的临床文献、技术白皮书、监管备案文件和公共采购文件的系统性回顾,以确定序列开发、现场人员利用和临床实践的趋势。一次研究包括与随机抽样的放射科医生、血管外科医生、影像技术人员、医院采购负责人和影像提供者的高级管理人员进行结构化访谈和讨论,以确保涵盖临床、营运和商业领域的多元化观点。

透过主题编码和比较分析整合定量和定性数据,并特别关注定序绩效指标、操作限制和采购考量。透过与临床和采购相关人员的后续讨论检验研究结果,以确认其与实际工作流程的相关性并完善解释。在整个过程中,我们注意对原始资讯进行匿名化处理,并记录方法学假设,以确保研究的可重复性和透明度。我们识别了研究的局限性和潜在偏差,确定了需要进一步深入研究的领域,并指南后续研究投入。

技术、临床和操作因素的结合将决定磁振造影血管造影术是否能够实现更广泛的临床整合和持续的价值创造

磁振造影血管血管造影术正处于技术创新、临床需求和经济压力交会的曲折点。高场和低场系统的进步、非造影和造影增强技术的改进以及人工智慧重建技术的整合,正在拓展磁振造影血管摄影的潜在临床应用。同时,关税变化、供应链重构和区域采购特性等结构性因素正在重塑组织取得和部署磁振造影血管摄影技术的能力。这两股力量既创造了价值创造的机会,也催生了策略调整的需求。

展望未来,相关人员产品开发与可证实的临床结果相结合、保持灵活筹资策略并投资于临床医生培训的利益相关者,将最有能力将技术潜力转化为常规临床效益。设备製造商、临床团队和影像IT提供者之间的跨学科合作将加速先进血管诊断在日常实践中的实现。简而言之,MRA的未来不仅取决于成像性能,还取决于生态系统提供便利、可靠且临床整合的解决方案的能力。

目录

第一章:前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将人工智慧演算法整合到 MRA 中,实现血管分割和病变量化的自动化
  • 采用高场7T系统提高脑血管影像分辨率
  • 针对肾功能不全患者的动脉自旋标记非造影MRA技术的开发
  • 扩展可携式和照护现场MRI 系统,用于加护病房的床边血管成像
  • 在 MRA 中实施基于深度学习的降噪可提高影像品质和诊断准确性
  • 紧凑型低场磁振造影血管摄影 (MRA) 扫描仪获得监管部门核准并进入市场,可用于经济高效的门诊病人血管评估
  • MRI 供应商和云端服务供应商合作实现即时远端 MRA 数据分析和远端医疗集成

第六章:2025年美国关税的累积影响

第七章:人工智慧的累积影响,2025年

第 8 章:磁振造影血管血管造影术设备市场(按产品)

  • 配件和耗材
  • 服务
  • 系统
    • 高场强系统
    • 低场强系统

9.磁振造影血管血管造影术设备市场(按场强)

  • 高场强
  • 低场强

第 10 章磁振造影血管血管造影术设备市场(按技术)

  • 对比增强
  • 相衬
  • 静止间隔单次拍摄
  • 飞行时间

第11章磁振造影血管血管造影术设备市场(按应用)

  • 心血管系统
    • 主动脉
  • 神经血管
    • 颅外
    • 颅内
  • 週边血管
    • 下肢
    • 上肢

第12章磁振造影血管血管造影术设备市场(按最终用户)

  • 学术研究机构
  • 门诊手术中心
  • 诊断影像中心
  • 医院

第 13 章:磁振造影血管血管造影术设备市场(按地区)

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第14章磁振造影血管血管造影术设备市场(依类别)

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章。按国家分類的磁振造影血管血管造影术设备市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Siemens Healthineers AG
    • GE Healthcare, Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Hitachi, Ltd.
    • Fujifilm Holdings Corporation
    • United Imaging Healthcare Co., Ltd.
    • Samsung Medison Co., Ltd.
    • Shimadzu Corporation
    • Esaote SpA
Product Code: MRR-A339DAEFA1A0

The Magnetic Resonance Angiography Market is projected to grow by USD 7.67 billion at a CAGR of 11.38% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.23 billion
Estimated Year [2025] USD 3.60 billion
Forecast Year [2032] USD 7.67 billion
CAGR (%) 11.38%

Concise framing of how modern magnetic resonance angiography innovations intersect with clinical needs, operational priorities, and organizational decision-making

Magnetic resonance angiography (MRA) occupies a critical nexus between diagnostic imaging innovation and vascular care pathways, offering clinicians noninvasive visualization of blood vessels across a spectrum of clinical settings. Recent technological progress has reduced procedural complexity, expanded clinical indications, and improved patient comfort, thereby elevating MRA from a niche modality to a pivotal diagnostic tool in many vascular workflows. These developments, driven by sequence innovation, hardware evolution, and software-enabled image reconstruction, have reshaped clinician expectations and procurement priorities.

Consequently, stakeholders across imaging departments, clinical research units, and device manufacturing must reassess how MRA integrates with broader diagnostic strategies. Radiology teams are increasingly prioritizing throughput and diagnostic confidence, while hospital administrators seek modalities that support multi-disciplinary uses and predictable lifecycle costs. At the same time, ambulatory centers and diagnostic imaging providers are evaluating how MRA can enhance service portfolios without imposing unsustainable operational burdens. This introduction situates MRA within the contemporary clinical and commercial landscape, emphasizing the interplay between technological capability, clinical uptake, and organizational decision-making.

Detailed exploration of the converging hardware, sequence, and computational trends that are redefining magnetic resonance angiography practice and procurement

The MRA landscape is experiencing transformative shifts driven by converging advances in hardware, pulse-sequence design, and computational imaging. High-field systems continue to push signal-to-noise boundaries and enable higher spatial resolution, yet parallel progress in low-field systems has revived interest due to cost-of-ownership advantages and improved accessibility. Simultaneously, non-contrast techniques such as time-of-flight and quiescent interval single shot have matured to reduce reliance on gadolinium-based agents, reshaping clinical protocols for patients with renal impairment and those requiring repeated imaging.

In parallel, phase contrast sequences and advanced contrast-enhanced methods have been refined for hemodynamic assessments, facilitating more nuanced evaluation of vascular flow and lesion characterization. Artificial intelligence and machine learning now play an increasingly central role in reconstruction, denoising, and automated vessel segmentation, shortening scan times and enhancing diagnostic yield. As a result, service models and consumable workflows are adapting to support hybrid offerings that combine high-end systems, optimized sequence libraries, and value-added software. These shifts collectively redefine procurement criteria and clinical pathways, making interoperability, upgradeability, and software licensing as influential as baseline hardware specifications.

Assessment of how new 2025 tariff measures in the United States are reshaping procurement strategies, supply chains, and capital planning across the magnetic resonance angiography ecosystem

The introduction of new tariffs in the United States in 2025 creates a complex environment for MRA stakeholders, affecting procurement cycles, sourcing decisions, and supplier relationships. Tariff-related cost pressures can raise the landed price of imported components and finished imaging systems, which in turn influences capital allocation and replacement timelines for hospitals, diagnostic centers, and ambulatory facilities. Faced with higher acquisition costs, many purchasers may defer upgrades or prioritize modular investments that can be staged over time, while others will scrutinize total cost of ownership more intensely, including maintenance contracts and consumable supply agreements.

Furthermore, tariff policies incentivize strategic supplier diversification and nearshoring, prompting manufacturers to reconfigure supply chains to mitigate exposure to tariff volatility. For service providers and consumable suppliers, tariffs may alter competitive dynamics as local production becomes relatively more attractive. In this context, procurement teams and clinical leaders must factor supply chain resilience into sourcing criteria, balancing potential short-term cost savings against the risks of single-source dependencies. Regulatory compliance and customs optimization will therefore assume greater importance, and stakeholders should be prepared to engage suppliers on inventory planning and contract flexibility to absorb episodic tariff impacts. Taken together, these adjustments will shape capital planning, vendor negotiations, and operational continuity throughout the imaging ecosystem.

In-depth segmentation synthesis revealing how product types, field strength tiers, imaging technologies, clinical applications, and end-user profiles collectively shape MRA demand and investment

A granular understanding of market segmentation illuminates where clinical demand and investment converge across the MRA landscape. When the market is parsed by product, distinct value streams emerge between accessories and consumables, ongoing service arrangements, and capital systems, with systems themselves bifurcating into high field strength and low field strength platforms that deliver different clinical capabilities and lifecycle economics. This dichotomy is mirrored when segmentation is organized by field strength alone, as high field strength and low field strength platforms each address separate clinical use cases and institutional budgets. Technology-based segmentation reveals how Contrast Enhanced procedures coexist alongside Phase Contrast methodologies, Quiescent Interval Single Shot techniques, and Time Of Flight approaches, each contributing unique diagnostic strengths and sequence-specific workflow requirements.

Application-focused segmentation further clarifies clinical trajectories, with cardiovascular applications encompassing both aortic and cardiac imaging needs, neurovascular practice differentiating between extracranial and intracranial indications, and peripheral vascular use cases delineating imaging of lower limb and upper limb territories. These clinical partitions interact with end-user categories, including academic research institutes, ambulatory surgical centers, diagnostic imaging centers, and hospitals, which vary markedly in procurement cycles, clinical throughput expectations, and staffing models. Consequently, product, field strength, technology, application, and end-user segments create overlapping demand pockets; by tracing these intersections, stakeholders can prioritize investments, tailor service offerings, and design clinical validation studies that resonate with the operational realities of each segment.

Comprehensive regional analysis showing how Americas, Europe Middle East & Africa, and Asia-Pacific each present distinct adoption patterns, procurement dynamics, and clinical priorities for MRA

Regional dynamics exert a profound influence on technology adoption, reimbursement frameworks, and clinical practice patterns across the global MRA landscape. In the Americas, clinical networks and large health systems often drive early adoption of high-performance systems and advanced sequence libraries, while variations in payer models and hospital funding introduce distinct procurement rhythms. Europe, Middle East & Africa present a heterogeneous mix of mature markets with established reimbursement pathways alongside emerging healthcare systems that prioritize cost-effective, scalable solutions; regulatory harmonization efforts and cross-border clinical collaborations further shape demand in these territories. Asia-Pacific exhibits rapid uptake in urban centers driven by expanding diagnostic infrastructures and increasing investment in noninvasive vascular diagnostics, yet market maturation varies widely between high-income metropolitan areas and resource-constrained regions where low-field systems and streamlined service models may be more practical.

Across these geographies, differences in clinical guidelines, training pipelines, and service delivery models influence how MRA is positioned relative to alternative imaging modalities. Vendors and service providers should therefore adopt region-specific engagement strategies that account for procurement cycles, local clinical champions, and regional regulatory considerations. Moreover, partnerships with regional research institutions and targeted clinical education programs can accelerate adoption where clinical demand and capacity align, while flexible commercial models can help bridge gaps in regions with constrained capital availability.

Strategic competitive analysis highlighting how integrated hardware, software, and service propositions determine vendor success in magnetic resonance angiography markets

Competitive dynamics in the MRA ecosystem are increasingly defined by integrated offerings that combine hardware, sequence libraries, post-processing software, and service contracts rather than standalone equipment sales. Original equipment manufacturers who can complement systems with robust software toolkits for vessel segmentation, flow quantification, and AI-enhanced reconstruction secure stronger footholds among large health systems that prize interoperability and roadmap clarity. Simultaneously, specialist vendors focused on consumables, coils, and procedural accessories compete on the basis of clinical compatibility, ease of integration, and predictable supply chains. Service providers that deliver responsive maintenance, remote diagnostics, and flexible training programs add tangible value for end users seeking uptime assurance and staff competency.

Strategic partnerships between imaging IT providers and clinical networks are also emerging as a differentiator, enabling longitudinal data analytics and quality improvement initiatives that extend the clinical utility of MRA. In this environment, companies that invest in clinical validation, provide transparent upgrade paths, and demonstrate strong regulatory compliance are better positioned to win complex, multi-stakeholder procurement decisions. For smaller firms, focusing on niche clinical applications, compelling economic value propositions, or novel contrast and non-contrast techniques can create defensible market positions. Ultimately, success rests on aligning product and service innovations with the operational realities of diverse clinical environments while managing supply chain and tariff-related risks through adaptive sourcing strategies.

Actionable strategic framework for industry leaders to optimize technology investments, supply chains, clinical validation, and commercialization of MRA solutions

Industry leaders should pursue a multi-pronged strategy to capture clinical value and mitigate external risks while accelerating MRA adoption across care settings. First, prioritize investments in sequence and software development that materially reduce scan time and enhance diagnostic confidence, enabling stronger clinical ROI narratives. Concurrently, diversify supply chains and explore regional manufacturing or assembly partnerships to buffer tariff exposure and improve lead times. These operational moves should be complemented by flexible commercial models that decouple capital acquisition from essential service and software revenues, giving purchasers options that align with their budget and clinical schedules.

Second, cultivate clinical evidence through targeted validation studies that demonstrate comparative performance across key use cases such as aortic imaging, cardiac vascular assessment, intracranial lesion characterization, and peripheral limb evaluation. Third, invest in training and change management programs to ensure radiology teams and technologists can extract maximum diagnostic value from new sequences and AI-based tools. Fourth, develop region-specific go-to-market plans that reflect reimbursement realities, regulatory nuances, and the varying adoption curves of high field versus low field systems. Finally, engage proactively with payers, health systems, and clinical societies to articulate the clinical and economic value of MRA-based pathways, thereby creating a supportive environment for sustainable adoption and scale.

Transparent description of the mixed-methods research approach combining secondary review, primary interviews, and rigorous validation to ensure reliable MRA insights

This research synthesizes insights gathered through a mixed-methods approach that emphasizes triangulation and stakeholder validation. Secondary analysis included a systematic review of peer-reviewed clinical literature, technical whitepapers, regulatory filings, and public procurement documentation to establish trends in sequence development, field strength utilization, and clinical practice. Primary research comprised structured interviews and consultations with a purposive sample of radiologists, vascular surgeons, imaging technologists, hospital procurement officers, and senior executives from imaging providers, ensuring diverse perspectives across clinical, operational, and commercial domains.

Quantitative and qualitative data were integrated through thematic coding and comparative analysis, with particular attention paid to sequence performance metrics, operational constraints, and purchasing considerations. Findings were validated through follow-up discussions with clinical and procurement stakeholders to confirm practical relevance and to calibrate interpretations against real-world workflows. Throughout the process, care was taken to anonymize primary-source inputs and to document methodological assumptions, enabling reproducibility and transparency. Limitations and potential biases are acknowledged, and areas identified for further primary study are noted to guide subsequent research investments.

Synthesis of technological, clinical, and operational factors that will determine whether magnetic resonance angiography achieves broader clinical integration and sustained value creation

Magnetic resonance angiography sits at an inflection point where technical innovation, clinical demand, and economic pressures converge. Advancements in both high-field and low-field systems, refinements in non-contrast and contrast-enhanced techniques, and the integration of AI-driven reconstruction are collectively expanding the modality's clinical applicability. At the same time, structural factors such as tariff changes, supply chain reconfiguration, and regional procurement idiosyncrasies are reshaping how organizations acquire and deploy MRA capabilities. These dual forces create both opportunities for value creation and imperatives for strategic adaptation.

Looking ahead, stakeholders that align product development with demonstrable clinical outcomes, maintain flexible sourcing strategies, and invest in clinician training will be best positioned to translate technological potential into routine clinical benefit. Cross-disciplinary collaboration between device manufacturers, clinical teams, and imaging IT providers will accelerate the realization of advanced vascular diagnostics in everyday practice. In short, MRA's future will be defined not only by imaging performance but also by the capacity of the ecosystem to deliver accessible, reliable, and clinically integrated solutions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms in MRA for automated vessel segmentation and lesion quantification
  • 5.2. Adoption of high-field 7T magnetic resonance angiography systems for improved cerebrovascular imaging resolution
  • 5.3. Development of non-contrast-enhanced MRA techniques using arterial spin labeling for patients with renal impairment
  • 5.4. Expansion of portable and point-of-care MRI systems for bedside vascular imaging in critical care settings
  • 5.5. Implementation of deep learning-based noise reduction in MRA to enhance image quality and diagnostic accuracy
  • 5.6. Regulatory approval and market entry of compact low-field MRA scanners for cost-effective outpatient vascular assessments
  • 5.7. Collaboration between MRI vendors and cloud service providers for real-time remote MRA data analysis and telemedicine integration

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Magnetic Resonance Angiography Market, by Product

  • 8.1. Accessories And Consumables
  • 8.2. Service
  • 8.3. Systems
    • 8.3.1. High Field Strength System
    • 8.3.2. Low Field Strength System

9. Magnetic Resonance Angiography Market, by Field Strength

  • 9.1. High Field Strength
  • 9.2. Low Field Strength

10. Magnetic Resonance Angiography Market, by Technology

  • 10.1. Contrast Enhanced
  • 10.2. Phase Contrast
  • 10.3. Quiescent Interval Single Shot
  • 10.4. Time Of Flight

11. Magnetic Resonance Angiography Market, by Application

  • 11.1. Cardiovascular
    • 11.1.1. Aortic
    • 11.1.2. Cardiac
  • 11.2. Neurovascular
    • 11.2.1. Extracranial
    • 11.2.2. Intracranial
  • 11.3. Peripheral Vascular
    • 11.3.1. Lower Limb
    • 11.3.2. Upper Limb

12. Magnetic Resonance Angiography Market, by End User

  • 12.1. Academic Research Institute
  • 12.2. Ambulatory Surgical Center
  • 12.3. Diagnostic Imaging Center
  • 12.4. Hospital

13. Magnetic Resonance Angiography Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Magnetic Resonance Angiography Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Magnetic Resonance Angiography Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Siemens Healthineers AG
    • 16.3.2. GE Healthcare, Inc.
    • 16.3.3. Koninklijke Philips N.V.
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Hitachi, Ltd.
    • 16.3.6. Fujifilm Holdings Corporation
    • 16.3.7. United Imaging Healthcare Co., Ltd.
    • 16.3.8. Samsung Medison Co., Ltd.
    • 16.3.9. Shimadzu Corporation
    • 16.3.10. Esaote S.p.A.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. MAGNETIC RESONANCE ANGIOGRAPHY MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. MAGNETIC RESONANCE ANGIOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. MAGNETIC RESONANCE ANGIOGRAPHY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SERVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HIGH FIELD STRENGTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOW FIELD STRENGTH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CONTRAST ENHANCED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PHASE CONTRAST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY QUIESCENT INTERVAL SINGLE SHOT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TIME OF FLIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AORTIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIAC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY EXTRACRANIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY INTRACRANIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY LOWER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY UPPER LIMB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY DIAGNOSTIC IMAGING CENTER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 214. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 272. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2018-2024 (USD MILLION)
  • TABLE 274. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY SYSTEMS, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY FIELD STRENGTH, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY CARDIOVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY NEUROVASCULAR, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PERIPHERAL VASCULAR, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 292. AFRICA MAGNETIC RESONANCE ANGIOGRAPHY MARKET SIZE, BY PRODUCT, 2025-2032 (